Cargando…
Candidate microRNA biomarkers of pancreatic ductal adenocarcinoma: meta-analysis, experimental validation and clinical significance
BACKGROUND: The diagnostic and prognostic value of microRNA (miRNA) expression aberrations in pancreatic ductal adenocarcinoma (PDAC) has been studied extensively in recent years. However, differences in measurement platforms and lab protocols as well as small sample sizes can render gene expression...
Autores principales: | Ma, Ming-Zhe, Kong, Xiang, Weng, Ming-Zhe, Cheng, Kun, Gong, Wei, Quan, Zhi-Wei, Peng, Cheng-Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4176285/ https://www.ncbi.nlm.nih.gov/pubmed/24289824 http://dx.doi.org/10.1186/1756-9966-32-71 |
Ejemplares similares
-
The State of the Art on Blood MicroRNAs in Pancreatic Ductal Adenocarcinoma
por: Gao, Zhuqing, et al.
Publicado: (2019) -
Expression and clinical significance of HSPA2 in pancreatic ductal adenocarcinoma
por: Zhang, Hui, et al.
Publicado: (2015) -
Prognostic value of microRNA-21 in pancreatic ductal adenocarcinoma: a meta-analysis
por: Hu, Geng-yuan, et al.
Publicado: (2016) -
Role of microRNAs in response to cadmium chloride in pancreatic ductal adenocarcinoma
por: Mortoglou, Maria, et al.
Publicado: (2021) -
microRNA-21 Regulates Stemness in Pancreatic Ductal Adenocarcinoma Cells
por: Mortoglou, Maria, et al.
Publicado: (2022)